Literature DB >> 24136584

Is reduced myocardial sympathetic innervation associated with clinical symptoms of autonomic impairment in idiopathic Parkinson's disease?

Daniel Guidez1, Stefanie Behnke, Ramona Halmer, Ulrich Dillmann, Klaus Faßbender, Carl M Kirsch, Dirk Hellwig, Jörg Spiegel.   

Abstract

Patients with idiopathic Parkinson's disease (IPD) have a reduced myocardial MIBG uptake in MIBG scintigraphy, indicating myocardial sympathetic denervation. We were interested whether this myocardial sympathetic denervation coincides with clinical symptoms of autonomic impairment in IPD patients. We performed MIBG scintigraphy, the SCOPA-AUT scale, a standardized medical history (developed in our clinic) and autonomic nervous system testing in 47 IPD patients (21 female, 26 male patients). We correlated myocardial MIBG uptake with the results of the SCOPA-AUT scale, the standardized medical history and the autonomic nervous system testing through the use of Spearman's correlation. Myocardial MIBG uptake correlated significantly (p < 0.05) with several items of the SCOPA-AUT scale (in female patients: perspiration during the night, in male patients: sum score, saliva dribbling of the mouth, difficulty swallowing, fainting, constipation), of the standardized medical history (in male patients: swollen ankles) and of the autonomic nervous system testing (all patients: sum score, Ewing orthostasis test). Remarkably, we found more significant correlations in male than in female patients. Reduced myocardial sympathetic innervation-as revealed by MIBG scintigraphy-is associated with clinical symptoms of autonomic impairment. This association is more pronounced in male than in female patients. The cause for this gender-specific phenomenon is unclear.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24136584     DOI: 10.1007/s00415-013-7135-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  29 in total

1.  [Total defect of metaiodobenzylguanidine (MIBG) imaging on heart in Parkinson's disease: assessment of cardiac sympathetic denervation].

Authors:  A Satoh; T Serita; M Tsujihata
Journal:  Nihon Rinsho       Date:  1997-01

2.  Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy.

Authors:  M Yoshita
Journal:  J Neurol Sci       Date:  1998-02-18       Impact factor: 3.181

3.  Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease.

Authors:  H Nagayama; M Hamamoto; M Ueda; J Nagashima; Y Katayama
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-02       Impact factor: 10.154

4.  Systemic blood pressure profile correlates with cardiac 123I-MIBG uptake in patients with Parkinson's disease.

Authors:  Yasuhiro Manabe; Daiki Fujii; Syoichiro Kono; Yasuko Sakai; Tomotaka Tanaka; Hisashi Narai; Nobuhiko Omori; Yutaka Imai; Koji Abe
Journal:  J Neurol Sci       Date:  2011-08-15       Impact factor: 3.181

Review 5.  The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes.

Authors:  S Braune
Journal:  Clin Auton Res       Date:  2001-12       Impact factor: 4.435

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

7.  (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.

Authors:  S Orimo; E Ozawa; S Nakade; T Sugimoto; H Mizusawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-08       Impact factor: 10.154

8.  SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy.

Authors:  Koldo Berganzo; Beatriz Tijero; Johanne H Somme; Verónica Llorens; Juan C Sánchez-Manso; David Low; Valeria Iodice; Ekawat Vichayanrat; Christopher J Mathias; Elena Lezcano; Juan J Zarranz; Juan C Gómez-Esteban
Journal:  Parkinsonism Relat Disord       Date:  2011-09-09       Impact factor: 4.891

9.  Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease.

Authors:  Jörg Spiegel; Dirk Hellwig; Georgios Farmakis; Wolfgang H Jost; Samuel Samnick; Klaus Fassbender; Carl-Martin Kirsch; Ulrich Dillmann
Journal:  Mov Disord       Date:  2007-05-15       Impact factor: 10.338

10.  A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure.

Authors:  M Hirayama; S Hakusui; Y Koike; K Ito; T Kato; M Ikeda; Y Hasegawa; A Takahashi
Journal:  J Auton Nerv Syst       Date:  1995-06-25
View more
  3 in total

1.  1-23I-MIBG thyroid uptake: Implications for MIBG imaging of the heart.

Authors:  Raffaele Giubbini; Elisa Milan; Claudio Marcassa; Barbara Paghera; Federica Fracassi; Luca Camoni; Carlo Rodella; Francesco Bertagna; Federica Motta; Mattia Bertoli; Riccardo Campini
Journal:  J Nucl Cardiol       Date:  2015-05-13       Impact factor: 5.952

2.  Co-morbidity and polypharmacy in Parkinson's disease: insights from a large Scottish primary care database.

Authors:  Gary McLean; John V Hindle; Bruce Guthrie; Stewart W Mercer
Journal:  BMC Neurol       Date:  2017-07-01       Impact factor: 2.474

3.  Relationship between the washout rate of I-123 MIBG scans and autonomic function in Parkinson's disease.

Authors:  Young Jin Jeong; Ji-Eun Jeong; Sang-Myung Cheon; Byeol-A Yoon; Jae Woo Kim; Do-Young Kang
Journal:  PLoS One       Date:  2020-03-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.